Study by Tioga Research Supports Efficacy of Leading Edge Pharms’ Liposomal Compound Silvidiol™

February 13th, 2019|

Study by Tioga Research Supports Efficacy of Leading Edge Pharms' Liposomal Compound Silvidiol™ Topical Cannabinoid Delivery System Demonstrates Ability to Permeate Skin to Reach Somatic and Neuropathic Sensory Receptors Without Systemic Exposure   HENDERSON, Nevada, February 13, 2019 -- Leading Edge Pharms, Inc., (LEP) a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the results of a Tioga Research-led study, indicating that its proprietary cannabidiol-based (CBD) pain relief and anti-inflammatory agent, Silvidiol™, effectively permeates the epidermis to reach somatic and neuropathic [...]

Leading Edge Pharms Adds New Pain Relief Ointment to CANNAVERA™ Product Line

January 29th, 2019|

Leading Edge Pharms Adds New Pain Relief Ointment to CANNAVERA™ Product Line New Silvidiol™ infused ointment ideal for pain relief and healthy skin maintenance HENDERSON, Nevada, Jan. 29, 2019 /PRNewswire/ -- Leading Edge Pharms, Inc. (LEP), a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the launch of a new pain relief ointment in their existing CANNAVERA product line of topical pain relief creams, sprays and oils. The new pain relief ointment is strengthened with nano-encapsulated Silvidiol™, a patent-pending proprietary compound of liposomal hemp and [...]

CARE Pharmacies and Leading Edge Pharms to Expand Access to Opioid Alternatives for Pain Management

December 17th, 2018|

CARE Pharmacies and Leading Edge Pharms to Expand Access to Opioid Alternatives for Pain Management CARE Pharmacies to offer CANNAVERA™ Topical Pain Relief products to its association member pharmacies nationwide   Henderson NV, December 17, 2018, /PRNewswire/ -- CARE Pharmacies Cooperative Inc. (CARE), a growing independent retail drug chain serving local communities throughout the United States, and Leading Edge Pharms, Inc. (Leading Edge), a biotechnology company developing novel cannabinoid therapies and innovative delivery platforms, announced today a preferred provider relationship for Leading Edge to [...]